How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

UB

NASDAQ:UBX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

UB

UNITY Biotechnology IncNASDAQ UBX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is UBX undervalued compared to its fair value?

The fair value of UBX stock is hidden USD. Relative to the market price of 1.45 USD UNITY Biotechnology Inc is hidden.

Unity Biotechnology, Inc. operates as a biotechnology company. The company is headquartered in South San Francisco, California and currently employs 32 full-time employees. The company went IPO on 2018-05-03. The firm is...[More about valuation]

UNITY Biotechnology Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.025 $B

Price:

1.45 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-1.047

FINANCIALS

UNITY Biotechnology financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0093 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.069 B
0.036 B

Financial Position Analysis

Assets

0.069 B
Current Assets
0.05 B
Total non-current assets
0.02 B

Total current liabilities
0.0086 B
Total non-current liabilities
0.025 B

Cash Flow Statement

-0.025 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0071 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

UNITY Biotechnology fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is UBX attractive for investment based on fundamental analysis?

UBX stock rating is hidden. UNITY Biotechnology is a hidden by Eyestock methodology.

Get UBX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

UBX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for UBX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

UNITY Biotechnology Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

UNITY Biotechnology Inc dividends

UBX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About UBX stock

About the company UNITY Biotechnology Inc

Market cap $B

0.025

Dividend yield

Shares outstanding

14.3391 B

Unity Biotechnology, Inc. operates as a biotechnology company. The company is headquartered in South San Francisco, California and currently employs 32 full-time employees. The company went IPO on 2018-05-03. The firm is engaged in developing a portfolio of programs targeting specific biological mechanisms implicated in diseases of aging. The firm is focused on creating senolytic medicines to selectively eliminate senescent cells and thereby treat diseases of aging, such as ophthalmologic diseases, with the opportunity to explore neurology and other therapeutic areas. The firm's product includes UBX1325, UBX2089 and UBX2050. UBX1325 is an advanced lead drug candidate for age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR). UBX2089, an α-Klotho hormone drug candidate, is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications. UBX2050 is investigating fully human anti-Tie2 agonist monoclonal antibody.

UBX profile

  • Ticker

    UBX

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    03 May 2018

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    32

  • City

    South San Francisco

  • Address

    285 East Grand Avenue

  • Cusip

    91381U200